Bimatoprost/Timolol Maleate

贝美前列素/马来酸噻吗洛尔

Report date: 2026/04/24 20:01:59

Base Information

Drug NameBimatoprost/Timolol Maleate
Drug Alias NameTimolol Maleate/Bimatoprost贝美前列素马来酸噻吗洛尔Bimatoprost and Timolol Maleate马来酸噻吗洛尔贝美前列素贝美前列素噻吗洛尔 +[8] 
ClassificationSmall molecules
Mechanisms of ActionProstanoid receptor agonistsBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptorsProstanoid receptor
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleOcular Hypertension
Approved Indications in ChinaGlaucoma, Open-AngleOcular Hypertension
Original Approved Country/TerritoryEU
Original Approved Date2006/05/19
Country/TerritoryBulgariaCanadaUnited States +[7] 
CombinationsYes BimatoprostTimolol Maleate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires Thea SASAllergan Pharmaceuticals Ireland LtdAbbvie Deutschland Gmbh & Co Kg
Inactive CompaniesAllergan Plc
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeS01ED51
Related LinksKEGG